EXELIXIS, INC. (EXEL)

Latest Insider Confidence Score

2026Q1

46.6
Bearish

Company insider confidence (by quarter)

2016Q4 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Papadopoulos Stelios Director 1,189,228 Nov 13, 2025
Haley Patrick J. EVP, Commercial 374,029 Nov 24, 2025
Wyszomierski Jack L Director 358,882 Jun 4, 2025
Goodman Vicki L EVP, Prod Dev & Med Aff &CMO 307,654 Apr 5, 2023
Hessekiel Jeffrey EVP & General Counsel 267,946 Mar 28, 2017

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 26, 2026 Mar 2, 2026 Aftab Dana EVP, Research and Development Neutral 85.0 +52,018 8.36% ✗ -
Feb 26, 2026 Mar 2, 2026 Senner Christopher J. CFO Neutral 85.0 +52,018 5.31% ✗ -
Feb 26, 2026 Mar 2, 2026 Hefti Brenda SVP and General Counsel Neutral 90.0 +23,119 22.66% ✗ -
Feb 26, 2026 Mar 2, 2026 Haley Patrick J. EVP, Commercial Neutral 90.0 +40,459 10.59% ✗ -
Feb 24, 2026 Mar 2, 2026 MORRISSEY MICHAEL CEO Neutral 77.5 +60,159 1.69% ✗ -
Feb 24, 2026 Feb 26, 2026 Aftab Dana EVP, Research and Development Sell 17.5 -47,918 -7.15% ✗ $2.1M
Feb 19, 2026 Feb 23, 2026 Aftab Dana EVP, Research and Development Sell 17.5 -29,873 -4.27% ✗ $1.3M
Feb 18, 2026 Feb 20, 2026 WYSZOMIERSKI JACK L Director Sell 8.8 -99,574 -26.24% ✓ $4.4M
Feb 17, 2026 Feb 19, 2026 Smith Julie Director Sell 17.5 -106,539 -63.30% ✗ $4.7M
Feb 13, 2026 Feb 18, 2026 Senner Christopher J. CFO Sell 17.5 -100,765 -9.33% ✗ $4.4M
Feb 15, 2026 Feb 18, 2026 Haley Patrick J. EVP, Commercial Sell 17.5 -99,297 -20.64% ✗ $4.3M
Feb 13, 2026 Feb 18, 2026 MORRISSEY MICHAEL CEO Sell 35.0 -489,996 -12.09% ✗ $21.5M
Feb 13, 2026 Feb 18, 2026 Eckhardt Sue Gail Director Sell 21.3 -3,856 -18.04% ✓ $168.9K
Feb 15, 2026 Feb 18, 2026 Aftab Dana EVP, Research and Development Sell 17.5 -39,205 -5.31% ✗ $1.7M
Feb 13, 2026 Feb 18, 2026 Oliver Bob Director Sell 17.5 -30,250 -58.89% ✗ $1.3M
Feb 15, 2026 Feb 18, 2026 Hefti Brenda SVP and General Counsel Sell 18.8 -24,099 -19.11% ✓ $1.1M
Jan 15, 2026 Jan 16, 2026 MORRISSEY MICHAEL CEO Sell 100.0 +408,549 12.97% ✗ $6.3M
Jan 15, 2026 Jan 16, 2026 Aftab Dana EVP, Research and Development Sell 100.0 +92,324 14.28% ✗ $1.2M
Jan 15, 2026 Jan 16, 2026 Haley Patrick J. EVP, Commercial Sell 100.0 +107,176 28.65% ✗ $1.5M
Jan 15, 2026 Jan 16, 2026 Senner Christopher J. CFO Sell 100.0 +109,015 11.23% ✗ $1.8M
Dec 3, 2025 Dec 5, 2025 Hefti Brenda SVP and General Counsel Neutral 90.0 +30,170 31.44% ✗ -
Nov 25, 2025 Nov 26, 2025 JOHNSON DAVID EDWARD Director Buy 87.5 +27,532 1.78% ✗ $1.2M
Nov 20, 2025 Nov 24, 2025 Haley Patrick J. EVP, Commercial Sell 17.5 -72,230 -16.19% ✗ $3M
Nov 21, 2025 Nov 24, 2025 Aftab Dana EVP, Research and Development Neutral 27.5 -24,000 -3.58% ✗ -
Nov 20, 2025 Hefti Brenda SVP and General Counsel Neutral 52.5 - 0.00% ✗ -
Nov 17, 2025 Nov 19, 2025 Oliver Bob Director Neutral 27.5 -1,044 -2.41% ✗ -
Nov 12, 2025 Nov 13, 2025 PAPADOPOULOS STELIOS Director Sell 17.5 -100,000 -7.76% ✗ $4.4M
Nov 11, 2025 Nov 13, 2025 MORRISSEY MICHAEL CEO Neutral 27.5 -240,000 -7.08% ✗ -
Nov 11, 2025 Nov 13, 2025 Aftab Dana EVP, Research and Development Sell 17.5 -48,383 -6.73% ✗ $2.1M
Nov 11, 2025 Nov 13, 2025 Beckerle Mary C Director Sell 17.5 -24,622 -53.52% ✗ $1M
Oct 8, 2025 Oct 10, 2025 Aftab Dana EVP, Research & Development Neutral 85.0 +50,673 7.58% ✗ -
Jun 2, 2025 Jun 4, 2025 Eckhardt Sue Gail Director Sell 7.5 -18,838 -46.84% ✓ $805.1K
Jun 3, 2025 Jun 4, 2025 WYSZOMIERSKI JACK L Director Sell 38.8 -7,535 -2.06% ✓ $324.7K
May 29, 2025 Jun 2, 2025 JOHNSON DAVID EDWARD Director Neutral 52.5 - 0.00% ✗ -
May 29, 2025 May 30, 2025 Beckerle Mary C Director Neutral 90.0 +9,812 32.27% ✗ -
May 29, 2025 May 30, 2025 Oliver Bob Director Neutral 90.0 +9,812 29.28% ✗ -
May 29, 2025 May 30, 2025 Heyman Tomas J. Director Neutral 90.0 +9,812 30.22% ✗ -
May 29, 2025 May 30, 2025 POSTE GEORGE Director Neutral 85.0 +9,812 5.81% ✗ -
May 29, 2025 May 30, 2025 WYSZOMIERSKI JACK L Director Neutral 82.5 +9,812 2.75% ✗ -
May 29, 2025 May 30, 2025 Freire Maria C Director Neutral 90.0 +9,812 10.78% ✗ -
May 29, 2025 May 30, 2025 PAPADOPOULOS STELIOS Director Neutral 67.5 +9,812 0.77% ✗ -
May 29, 2025 May 30, 2025 Eckhardt Sue Gail Director Neutral 90.0 +9,812 32.27% ✗ -
May 29, 2025 May 30, 2025 Smith Julie Director Neutral 90.0 +9,812 91.04% ✗ -
May 20, 2025 May 22, 2025 Haley Patrick J. EVP, Commercial Sell 17.5 -34,387 -7.15% ✗ $1.5M
May 21, 2025 May 22, 2025 Heyman Tomas J. Director Sell 22.5 -4,544 -12.28% ✗ $201.3K
May 16, 2025 May 16, 2025 POSTE GEORGE Director Sell 20.0 -20,634 -10.88% ✗ $949K
May 15, 2025 May 16, 2025 Aftab Dana CSO/EVP Disc & Trans Research Sell 17.5 -30,693 -4.39% ✗ $1.4M
May 15, 2025 May 16, 2025 Senner Christopher J. CFO Sell 16.3 -141,422 -6.80% ✗ $6.4M
May 15, 2025 May 16, 2025 PAPADOPOULOS STELIOS Director Sell 17.5 -36,508 -1.41% ✗ $1.6M
May 14, 2025 May 16, 2025 MORRISSEY MICHAEL CEO Sell 35.0 -325,263 -8.76% ✗ $14.5M
May 15, 2025 May 16, 2025 Hessekiel Jeffrey EVP & General Counsel Sell 17.5 -59,035 -7.84% ✗ $2.7M
May 14, 2025 May 16, 2025 Haley Patrick J. EVP, Commercial Sell 22.5 -171,088 -8.36% ✓ $8M
May 15, 2025 May 16, 2025 Peterson Amy C. EVP Prod Dev & Med Aff & CMO Sell 17.5 -81,079 -7.76% ✗ $3.7M
May 1, 2025 May 5, 2025 Aftab Dana CSO/EVP Disc & Trans Research Sell 40.0 -1,508 -0.22% ✗ $58.8K
Mar 31, 2025 Mar 31, 2025 Peterson Amy C. EVP Prod Dev & Med Aff & CMO Neutral 90.0 +159,383 45.92% ✗ -
Mar 31, 2025 Mar 31, 2025 MORRISSEY MICHAEL CEO Neutral 90.0 +589,719 20.94% ✗ -
Mar 31, 2025 Mar 31, 2025 Aftab Dana CSO/EVP Disc & Trans Research Neutral 90.0 +132,819 23.43% ✗ -
Mar 31, 2025 Mar 31, 2025 Hessekiel Jeffrey EVP & General Counsel Neutral 90.0 +154,070 25.74% ✗ -
Mar 31, 2025 Mar 31, 2025 Haley Patrick J. EVP, Commercial Neutral 90.0 +159,383 42.48% ✗ -
Mar 31, 2025 Mar 31, 2025 Senner Christopher J. CFO Neutral 90.0 +170,009 20.19% ✗ -
Mar 3, 2025 Mar 5, 2025 Haley Patrick J. EVP, Commercial Sell 38.8 -10,000 -2.60% ✓ $388K
Feb 27, 2025 Feb 28, 2025 Smith Julie Director Sell 17.5 -73,808 -77.40% ✗ $2.8M
Feb 26, 2025 Feb 28, 2025 MORRISSEY MICHAEL CEO Neutral 85.0 +184,909 7.03% ✗ -
Feb 26, 2025 Feb 28, 2025 Aftab Dana CSO/EVP Disc & Trans Research Neutral 85.0 +49,209 9.50% ✗ -
Feb 26, 2025 Feb 28, 2025 Haley Patrick J. EVP, Commercial Neutral 90.0 +47,718 14.14% ✗ -
Feb 26, 2025 Feb 28, 2025 Hessekiel Jeffrey EVP & General Counsel Neutral 85.0 +52,192 9.55% ✗ -
Feb 26, 2025 Feb 28, 2025 Peterson Amy C. EVP Prod Dev & Med Aff & CMO Neutral 90.0 +52,192 17.70% ✗ -
Feb 28, 2025 Feb 28, 2025 WYSZOMIERSKI JACK L Director Sell 38.8 -8,768 -2.40% ✓ $331.4K
Feb 26, 2025 Feb 28, 2025 Senner Christopher J. CFO Neutral 85.0 +59,648 7.62% ✗ -
Feb 24, 2025 Feb 26, 2025 Haley Patrick J. EVP, Commercial Sell 17.5 -52,636 -13.49% ✗ $1.9M
Feb 25, 2025 Feb 26, 2025 Oliver Bob Director Sell 20.0 -18,647 -35.75% ✗ $694.6K
Feb 24, 2025 Feb 26, 2025 Aftab Dana CSO/EVP Disc & Trans Research Sell 20.0 -26,987 -4.95% ✗ $991.8K
Feb 24, 2025 Feb 26, 2025 MORRISSEY MICHAEL CEO Neutral 52.5 - 0.00% ✗ -
Feb 24, 2025 Feb 26, 2025 Senner Christopher J. CFO Sell 17.5 -29,314 -3.61% ✗ $1.1M
Feb 15, 2025 Feb 19, 2025 Senner Christopher J. CFO Sell 20.0 -21,591 -2.69% ✗ $755.7K
Feb 14, 2025 Feb 19, 2025 Beckerle Mary C Director Sell 20.0 -12,210 -28.65% ✗ $425.9K
Feb 14, 2025 Feb 19, 2025 POSTE GEORGE Director Sell 20.0 -15,874 -8.59% ✗ $551.5K
Feb 15, 2025 Feb 19, 2025 Hessekiel Jeffrey EVP & General Counsel Sell 20.0 -18,134 -3.21% ✗ $634.7K
Feb 15, 2025 Feb 19, 2025 Haley Patrick J. EVP, Commercial Sell 20.0 -18,906 -4.62% ✗ $661.7K
Feb 15, 2025 Feb 19, 2025 Aftab Dana CSO/EVP Disc & Trans Research Sell 17.5 -28,748 -5.01% ✗ $1M
Feb 14, 2025 Feb 19, 2025 Freire Maria C Director Sell 17.5 -44,114 -32.65% ✗ $1.5M
Feb 15, 2025 Feb 19, 2025 MORRISSEY MICHAEL CEO Sell 17.5 -63,570 -2.36% ✗ $2.2M
Feb 14, 2025 Feb 19, 2025 Eckhardt Sue Gail Director Sell 20.0 -11,568 -27.56% ✗ $405.1K
Jan 16, 2025 Jan 17, 2025 MORRISSEY MICHAEL CEO Sell 100.0 +352,982 15.07% ✗ $4.5M
Jan 16, 2025 Jan 17, 2025 Senner Christopher J. CFO Sell 100.0 +97,024 13.73% ✗ $1.3M
Jan 16, 2025 Jan 17, 2025 Hessekiel Jeffrey EVP & General Counsel Sell 97.5 +92,491 19.59% ✗ $979.8K
Jan 16, 2025 Jan 17, 2025 Aftab Dana CSO/EVP Disc & Trans Research Sell 97.5 +81,536 16.57% ✗ $841.2K
Jan 16, 2025 Jan 17, 2025 Haley Patrick J. EVP, Commercial Sell 100.0 +96,187 30.75% ✗ $1M
Dec 20, 2024 Dec 23, 2024 MORRISSEY MICHAEL CEO Neutral 52.5 - 0.00% ✗ -
Nov 27, 2024 Dec 2, 2024 Hessekiel Jeffrey EVP & General Counsel Sell 36.3 -173,908 -26.92% ✗ $5.8M
Nov 22, 2024 Nov 26, 2024 Haley Patrick J. EVP, Commercial Sell 35.0 -10,000 -3.10% ✓ $352.7K
Nov 15, 2024 Nov 19, 2024 Senner Christopher J. CFO Sell 20.0 -17,506 -2.42% ✗ $613.6K
Nov 15, 2024 Nov 19, 2024 MORRISSEY MICHAEL CEO Sell 17.5 -47,642 -1.99% ✗ $1.7M
Nov 15, 2024 Nov 19, 2024 Haley Patrick J. EVP, Commercial Sell 20.0 -56,260 -14.84% ✓ $1.9M
Nov 15, 2024 Nov 19, 2024 Hessekiel Jeffrey EVP & General Counsel Sell 20.0 -14,672 -2.76% ✗ $514.3K
Nov 15, 2024 Nov 19, 2024 Aftab Dana CSO/EVP Disc & Trans Research Sell 20.0 -12,838 -2.54% ✗ $450K
Nov 15, 2024 Nov 19, 2024 Peterson Amy C. EVP Prod Dev & Med Aff & CMO Sell 20.0 -27,224 -8.45% ✗ $954.2K
Nov 5, 2024 Nov 7, 2024 Aftab Dana CSO/EVP Disc & Trans Research Sell 15.0 -96,986 -16.12% ✓ $3.4M
Nov 1, 2024 Nov 5, 2024 Hessekiel Jeffrey EVP & General Counsel Sell 23.8 -50,000 -8.60% ✓ $1.7M
Nov 1, 2024 Nov 5, 2024 POSTE GEORGE Director Sell 17.5 -30,000 -15.07% ✗ $1M